|
GTEX-1LB8K
|
51-60
|
Male
|
GTEX-1LB8K-1526 |
Gastroesophageal junction
|
PAXgene |
1
|
6 pieces; minute submucosal gland 0.3 mm [labeled]; 25% fat in 1 pair
|
Acceptable
|
 |
|
GTEX-1LB8K
|
51-60
|
Male
|
GTEX-1LB8K-2926 |
Pituitary gland
|
PAXgene |
1
|
1 piece; all adenohypophysis
|
Acceptable
|
 |
|
GTEX-1LBAC
|
21-40
|
Male
|
GTEX-1LBAC-0626 |
Minor salivary glands
|
PAXgene |
0
|
2 pieces; salivary gland elements with minimal attached stroma
|
Acceptable
|
 |
|
GTEX-1LBAC
|
21-40
|
Male
|
GTEX-1LBAC-0726 |
Thyroid gland
|
PAXgene |
0
|
2 pieces
|
Acceptable
|
 |
|
GTEX-1LC47
|
61-70
|
Male
|
GTEX-1LC47-0726 |
Thyroid gland
|
PAXgene |
1
|
2 pieces, 5mm calcifying adenomatoid nodule, encircled. Regressive changes
|
Acceptable
|
 |
|
GTEX-1LC47
|
61-70
|
Male
|
GTEX-1LC47-2726 |
Pituitary gland
|
PAXgene |
1
|
1 piece; mainly neurohypophysis, ~4.5mm, delineated--smaller nubbins of adenohypophysis encircled
|
Acceptable
|
 |
|
GTEX-1LG7Y
|
51-60
|
Male
|
GTEX-1LG7Y-0626 |
Thyroid gland
|
PAXgene |
1
|
2 pieces, feature of goitre; trace nubbins of fat/fibrous tissue up to ~1mm, delineated
|
Acceptable
|
 |
|
GTEX-1LG7Y
|
51-60
|
Male
|
GTEX-1LG7Y-2926 |
Pituitary gland
|
PAXgene |
1
|
1 piece, ~20% neurohypophysis (delineated, ~5mm focus); rest is adenohypophysis
|
Acceptable
|
 |
|
GTEX-1LG7Z
|
21-40
|
Male
|
GTEX-1LG7Z-0526 |
Thyroid gland
|
PAXgene |
1
|
2 pieces; 1 with up to 2.3mm adherent skeletal muscle [labeled]
|
Acceptable
|
 |
|
GTEX-1LGRB
|
51-60
|
Female
|
GTEX-1LGRB-1226 |
Thyroid gland
|
PAXgene |
1
|
2 pieces; nodular goiter
|
Acceptable
|
 |
|
GTEX-1LH75
|
51-60
|
Female
|
GTEX-1LH75-0626 |
Thyroid gland
|
PAXgene |
1
|
2 pieces, no abnormalities
|
Acceptable
|
 |
|
GTEX-1LH75
|
51-60
|
Female
|
GTEX-1LH75-3026 |
Pituitary gland
|
PAXgene |
1
|
1 piece, ~80% adenohypophysis; ~20% neurohypophysis, delineated, 3.5 x1.5mm nubbin
|
Acceptable
|
 |
|
GTEX-1LKK1
|
51-60
|
Female
|
GTEX-1LKK1-0826 |
Thyroid gland
|
PAXgene |
1
|
2 pieces, no abnormalities
|
Acceptable
|
 |
|
GTEX-1LKK1
|
51-60
|
Female
|
GTEX-1LKK1-3026 |
Pituitary gland
|
PAXgene |
2
|
1 piece, ~15-20% neurohypophysis, delineated; rest is adenohypophysis; partial rim of adherent dura up to ~1.5mm
|
Acceptable
|
 |
|
GTEX-1LNCM
|
51-60
|
Female
|
GTEX-1LNCM-0126 |
Thyroid gland
|
PAXgene |
1
|
2 pieces; nodular hyperplasia with regressive changes
|
Acceptable
|
 |
|
GTEX-1LSNL
|
51-60
|
Male
|
GTEX-1LSNL-1026 |
Thyroid gland
|
PAXgene |
3
|
2 pieces, advanced autolysis
|
Acceptable
|
 |
|
GTEX-1LSNL
|
51-60
|
Male
|
GTEX-1LSNL-3226 |
Pituitary gland
|
PAXgene |
1
|
1 piece, ~90% adenohypophysis with ~1.5 mm nodule of neurohypophysis, delineated
|
Acceptable
|
 |
|
GTEX-1LSNM
|
51-60
|
Male
|
GTEX-1LSNM-0226 |
Thyroid gland
|
PAXgene |
1
|
2 pieces; nodular hyperplasia
|
Acceptable
|
 |
|
GTEX-1LSNM
|
51-60
|
Male
|
GTEX-1LSNM-1526 |
Minor salivary glands
|
PAXgene |
1
|
2 pieces; nerve/stroma/skeletal muscle, no salivary gland elements
|
Unacceptable
|
 |
|
GTEX-1LSVX
|
61-70
|
Male
|
GTEX-1LSVX-0726 |
Thyroid gland
|
PAXgene |
2
|
2 pieces; 2 adenomatoid nodules <2mm
|
Acceptable
|
 |
|
GTEX-1LSVX
|
61-70
|
Male
|
GTEX-1LSVX-2326 |
Minor salivary glands
|
PAXgene |
1
|
2 pieces; <1mm salivary gland; remainder is lip and connective tissue
|
Unacceptable
|
 |
|
GTEX-1LSVX
|
61-70
|
Male
|
GTEX-1LSVX-2626 |
Pituitary gland
|
PAXgene |
1
|
1 piece; mostly anterior lobe; posterior labeled
|
Acceptable
|
 |
|
GTEX-1LVA9
|
51-60
|
Male
|
GTEX-1LVA9-0626 |
Thyroid gland
|
PAXgene |
2
|
2 pieces; moderately to severely autolyzed, ~15% of 1 piece is fat/vessels
|
Acceptable
|
 |
|
GTEX-1LVA9
|
51-60
|
Male
|
GTEX-1LVA9-2526 |
Minor salivary glands
|
PAXgene |
1
|
2 pieces; 1 piece is portion of lip, 2nd is salivary gland elements with attachment of fat (~20%)
|
Acceptable
|
 |
|
GTEX-1LVA9
|
51-60
|
Male
|
GTEX-1LVA9-3226 |
Pituitary gland
|
PAXgene |
2
|
1 piece; mild to moderate autolysis, predominantly adenohypophysis
|
Acceptable
|
 |